These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1721 related articles for article (PubMed ID: 28794019)

  • 1. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
    Vang L; Morello CS; Mendy J; Thompson D; Manayani D; Guenther B; Julander J; Sanford D; Jain A; Patel A; Shabram P; Smith J; Alexander J
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009195. PubMed ID: 33711018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zika virus-like particle (VLP) based vaccine.
    Boigard H; Alimova A; Martin GR; Katz A; Gottlieb P; Galarza JM
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005608. PubMed ID: 28481898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
    Garg H; Mehmetoglu-Gurbuz T; Ruddy GM; Joshi A
    Vaccine; 2019 Nov; 37(48):7123-7131. PubMed ID: 31607605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
    De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
    Espinosa D; Mendy J; Manayani D; Vang L; Wang C; Richard T; Guenther B; Aruri J; Avanzini J; Garduno F; Farness P; Gurwith M; Smith J; Harris E; Alexander J
    EBioMedicine; 2018 Jan; 27():61-70. PubMed ID: 29269041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge.
    Thompson D; Guenther B; Manayani D; Mendy J; Smith J; Espinosa DA; Harris E; Alexander J; Vang L; Morello CS
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010588. PubMed ID: 35793354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice.
    Dai S; Zhang T; Zhang Y; Wang H; Deng F
    Virol Sin; 2018 Jun; 33(3):213-226. PubMed ID: 29774519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
    Alvim RGF; Itabaiana I; Castilho LR
    Vaccine; 2019 Nov; 37(47):6970-6977. PubMed ID: 31164305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zika virus like particles elicit protective antibodies in mice.
    Salvo MA; Kingstad-Bakke B; Salas-Quinchucua C; Camacho E; Osorio JE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006210. PubMed ID: 29401460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal immunization with a DNA vaccine candidate elicits specific passive protection against post-natal Zika virus infection in immunocompetent BALB/c mice.
    Wang R; Liao X; Fan D; Wang L; Song J; Feng K; Li M; Wang P; Chen H; An J
    Vaccine; 2018 Jun; 36(24):3522-3532. PubMed ID: 29753607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
    Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models.
    Guo Q; Chan JF; Poon VK; Wu S; Chan CC; Hou L; Yip CC; Ren C; Cai JP; Zhao M; Zhang AJ; Song X; Chan KH; Wang B; Kok KH; Wen Y; Yuen KY; Chen W
    J Infect Dis; 2018 Jul; 218(3):365-377. PubMed ID: 29617816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein.
    Li A; Yu J; Lu M; Ma Y; Attia Z; Shan C; Xue M; Liang X; Craig K; Makadiya N; He JJ; Jennings R; Shi PY; Peeples ME; Liu SL; Boyaka PN; Li J
    Nat Commun; 2018 Aug; 9(1):3067. PubMed ID: 30076287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zika virus structural biology and progress in vaccine development.
    Lin HH; Yip BS; Huang LM; Wu SC
    Biotechnol Adv; 2018; 36(1):47-53. PubMed ID: 28916391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage.
    Xu K; Song Y; Dai L; Zhang Y; Lu X; Xie Y; Zhang H; Cheng T; Wang Q; Huang Q; Bi Y; Liu WJ; Liu W; Li X; Qin C; Shi Y; Yan J; Zhou D; Gao GF
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
    Whitbeck JC; Thomas A; Kadash-Edmondson K; Grinyo-Escuer A; Stafford LJ; Cheng C; Liao GC; Holtsberg FW; Aman MJ; Simmons G; Davidson E; Doranz BJ
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008730. PubMed ID: 33206639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.